Vidhi Research and Development LLP entered into a business transfer agreement to acquire Thane Plant from Pfizer Limited (BSE:500680) for INR 1.8 billion on September 23, 2015. Upon the conclusion of the transaction, all current workmen at the Thane Plant will be transferred to Vidhi Research so as to facilitate manufacturing operations. Transaction is expected to be completed by March, 2017. As of December 11, 2015, Competition Commission approved the acquisition.

Abhijit Joshi and Nandish Vyas of Veritas Legal acted as legal advisor for Pfizer Limited. Tushar Mavani and S R Patnaik of Cyril Amarchand Mangaldas acted as legal advisor for Vidhi Research and Development LLP.

Vidhi Research and Development LLP completed the acquisition of Thane Plant from Pfizer Limited (BSE:500680) on February 24, 2023. As on July 3, 2019, Pfizer Limited (BSE:500680) received approval of Maharashtra Industrial Development Corporation for the transfer of the business undertaking including the land, plant & machinery and employees, save and except certain portion of the land which is subject to pending proceedings.